Current Immune Therapies of Autoimmune Disease of the Nervous System with Special Emphasis to Multiple Sclerosis
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
4513-4517
Author(s):
Karl Vass
Therapeutic Monitoring of Immunotherapies in Autoimmune Diseases
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
4550-4555
Author(s):
Nicolas von Ahsen and Andrew Chan
The Genetics of Small-Vessel Disease
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
4124-4141
Author(s):
A. Bersano, S. Debette, E. R. Zanier, S. Lanfranconi, M. G. De Simoni, O. Zuffardi and G. Micieli
GEMSP: A New Therapeutic Approach to Multiple Sclerosis
Journal:
Central Nervous System Agents in Medicinal Chemistry
Volume:
12
Page:
173-181
Author(s):
Michel Geffard, Sebastien Duleu, Alban Bessede, Valerie Vigier, Dominique Bodet, Arturo Mangas and Rafael Covenas
Opiate Drug Use and the Pathophysiology of NeuroAIDS
Journal:
Current HIV Research
Volume:
10
Page:
435-452
Author(s):
Kurt F. Hauser, Sylvia Fitting, Seth M. Dever, Elizabeth M. Podhaizer and Pamela E. Knapp
Biologic Therapies in Primary Sjögren's Syndrome
Journal:
Current Pharmaceutical Biotechnology
Volume:
13
Page:
1997-2008
Author(s):
S. J. Bowman
In Vitro and In Vivo Models of Multiple Sclerosis
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
11
Page:
570-588
Author(s):
Baukje J. van der Star, Daphne Y.S. Vogel, Markus Kipp, Fabiola Puentes, David Baker and Sandra Amor
Pathology of Multiple Sclerosis
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
11
Page:
506-517
Author(s):
Markus Kipp, Paul van der Valk and Sandra Amor
Disease Modifying Drugs in Multiple Sclerosis: Mechanisms of Action and New Drugs in the Horizon
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
11
Page:
610-623
Author(s):
Monica Marta and Gavin Giovannoni
Viruses and Multiple Sclerosis
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
11
Page:
528-544
Author(s):
Jussi Oskari Virtanen and Steve Jacobson